PL360967A1 - Kompozycja farmaceutyczna zawierająca chlorowodorek donepezylu - Google Patents

Kompozycja farmaceutyczna zawierająca chlorowodorek donepezylu

Info

Publication number
PL360967A1
PL360967A1 PL03360967A PL36096703A PL360967A1 PL 360967 A1 PL360967 A1 PL 360967A1 PL 03360967 A PL03360967 A PL 03360967A PL 36096703 A PL36096703 A PL 36096703A PL 360967 A1 PL360967 A1 PL 360967A1
Authority
PL
Poland
Prior art keywords
donepezyl
hydrochloride
compound containing
pharmaceutical compound
pharmaceutical
Prior art date
Application number
PL03360967A
Other languages
English (en)
Inventor
Alexander Weisman
Chalil Abu Gnim
Rina Uzan
Joseph Kaspi
Original Assignee
Chemagis Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemagis Ltd. filed Critical Chemagis Ltd.
Publication of PL360967A1 publication Critical patent/PL360967A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL03360967A 2002-07-01 2003-06-30 Kompozycja farmaceutyczna zawierająca chlorowodorek donepezylu PL360967A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL150509A IL150509A (en) 2002-07-01 2002-07-01 Pharmaceutical preparations containing donafazil hydrochloride

Publications (1)

Publication Number Publication Date
PL360967A1 true PL360967A1 (pl) 2004-01-12

Family

ID=29596302

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03360967A PL360967A1 (pl) 2002-07-01 2003-06-30 Kompozycja farmaceutyczna zawierająca chlorowodorek donepezylu

Country Status (7)

Country Link
US (1) US6734195B2 (pl)
EP (1) EP1378238A1 (pl)
JP (1) JP4855642B2 (pl)
AU (1) AU2003205007B2 (pl)
CA (1) CA2433585C (pl)
IL (1) IL150509A (pl)
PL (1) PL360967A1 (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1163901B1 (en) * 1999-02-26 2008-09-10 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
US20050227911A1 (en) * 2001-09-28 2005-10-13 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
US20050249786A1 (en) * 2001-09-28 2005-11-10 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
US20050233003A1 (en) * 2001-09-28 2005-10-20 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
US20050191359A1 (en) * 2001-09-28 2005-09-01 Solubest Ltd. Water soluble nanoparticles and method for their production
US6878693B2 (en) * 2001-09-28 2005-04-12 Solubest Ltd. Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
US7700851B2 (en) * 2001-11-13 2010-04-20 U.S. Smokeless Tobacco Company Tobacco nicotine demethylase genomic clone and uses thereof
IL154370A0 (en) * 2003-02-10 2003-09-17 Chemagis Ltd Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
US7186842B2 (en) * 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
WO2005065645A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
AU2005288521A1 (en) * 2004-09-29 2006-04-06 Chemagis Ltd. Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
EP2039349A1 (en) 2004-10-19 2009-03-25 KRKA, tovarna zdravil, d.d., Novo mesto Solid pharmaceutical composition comprising donepezil hydrochloride
WO2006063025A1 (en) * 2004-12-07 2006-06-15 Nektar Therapeutics Stable non-crystalline formulation comprising donepezil
US20080171736A1 (en) * 2004-12-23 2008-07-17 Gregory Christopher W Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
CA2592605C (en) * 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2006090263A1 (en) * 2005-02-28 2006-08-31 Ranbaxy Laboratories Limited Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions
WO2007018801A1 (en) * 2005-07-28 2007-02-15 Teikoku Pharma Usa, Inc. Gelled donepezil compositions and methods for making and using the same
WO2007108011A2 (en) * 2006-03-20 2007-09-27 Ind-Swift Laboratories Limited Process for the preparation of highly pure donepezil
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US8012994B1 (en) 2006-09-22 2011-09-06 Sevastyanov Victor V Method for the treatment of sensorineural hearing loss with donepezil hydrochloride (ARICEPT®)
MX2009012583A (es) * 2007-05-22 2010-03-08 Otsuka Pharma Co Ltd Un medicamento que comprende un derivado de carbostirilo y donepezilo para tratar enfermedad de alzheimer.
DE102007037932A1 (de) * 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
US7985695B2 (en) * 2007-09-28 2011-07-26 Canon Kabushiki Kaisha Forming silicon oxide film from RF plasma of oxidizing gas
US20090221554A1 (en) * 2008-02-28 2009-09-03 Zenyaku Kogyo Kabushiki Kaisha Method of treating cognitive impairment
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
US8458871B2 (en) * 2008-06-26 2013-06-11 Hg-Farley Laserlab Co. Pty Ltd Secondary positioning device for workpiece machining
CN102164601A (zh) * 2008-09-30 2011-08-24 帝国制药美国公司 经皮延长给药多奈哌齐组合物及其使用方法
US20140370011A1 (en) * 2009-06-04 2014-12-18 Dara Biosciences, Inc. Methods of treating or preventing cognitive impairment using indane acetic acid derivatives
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
EP2366378A1 (en) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Sustained-release donepezil formulations
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
EP2502620A1 (en) 2011-03-24 2012-09-26 Krka Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising donepezil
CN112055584A (zh) * 2018-04-30 2020-12-08 拜耳公司 sGC活化剂和sGC刺激剂用于治疗认知障碍的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
WO1997046526A1 (en) 1996-06-07 1997-12-11 Eisai Co., Ltd. Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
AU731282B2 (en) 1996-06-07 2001-03-29 Eisai Co. Ltd. Polymorphs of donepezil hydrochloride and process for production
TW513409B (en) 1996-06-07 2002-12-11 Eisai Co Ltd Polymorphs of donepezil hydrochloride
US6372760B1 (en) 1999-03-31 2002-04-16 Eisai Co., Ltd. Stabilized composition comprising antidementia medicament
JP3952348B2 (ja) * 1999-07-02 2007-08-01 セイコーエプソン株式会社 低吸液性印刷用紙に用いられるブラックインク組成物
EP1120109A3 (en) * 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form
PT1260215E (pt) * 2000-03-01 2009-09-03 Eisai R&D Man Co Ltd Comprimido de desintegração rápida que contém poli(álcool vinílico)
AU2001239052A1 (en) * 2000-03-06 2001-09-17 Immune Network Ltd. Compositions for prevention and treatment of dementia
SI21223A (sl) 2002-06-19 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom

Also Published As

Publication number Publication date
JP4855642B2 (ja) 2012-01-18
CA2433585A1 (en) 2004-01-01
US6734195B2 (en) 2004-05-11
CA2433585C (en) 2010-11-23
AU2003205007A1 (en) 2004-01-15
IL150509A0 (en) 2003-02-12
JP2004131469A (ja) 2004-04-30
IL150509A (en) 2007-07-04
AU2003205007B2 (en) 2008-07-03
US20040002517A1 (en) 2004-01-01
EP1378238A1 (en) 2004-01-07

Similar Documents

Publication Publication Date Title
GB0218625D0 (en) Pharmaceutical compounds
EG27104A (en) Pharmaceutical compounds
GB0217225D0 (en) Medicinal compounds
GB0225540D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0225535D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
GB0225030D0 (en) Medicinal compounds
GB0315657D0 (en) Pharmaceutical compounds
GB0215775D0 (en) Pharmaceutical compounds
GB0308511D0 (en) Pharmaceutical compounds
GB0317315D0 (en) Pharmaceutical compounds
EP1484061A4 (en) DRUGS CONTAINING COMPOUNDS OF THE RIBOFLAVIN TYPE
GB0313766D0 (en) Pharmaceutical compounds
GB0206505D0 (en) Pharmaceutical combination
AU2003291642A8 (en) Pyrazoloazepine compounds as pharmaceutical agents
GB0301736D0 (en) Pharmaceutical compounds
GB0204392D0 (en) Pharmaceutical compound
GB0310361D0 (en) Pharmaceutical compound
GB0329617D0 (en) Pharmaceutical compounds
GB0204391D0 (en) Pharmaceutical compound
GB0212462D0 (en) Pharmaceutical compound
GB0212459D0 (en) Pharmaceutical compound
GB0208248D0 (en) Pharmaceutical compounds
GB0230153D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)